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Abstract
Disruption of protein folding in the endoplasmic reticulum (ER) causes ER stress. Activation
of the unfolded protein response (UPR) acts to restore protein homeostasis or, if ER stress
is severe or persistent, drive apoptosis, which is thought to proceed through the cell intrinsic,
mitochondrial pathway. Indeed, cells that lack the key executioner proteins BAX and BAK
are protected from ER stress-induced apoptosis. Here we show that chronic ER stress
causes the progressive inhibition of the extracellular signal-regulated kinase (ERK1/2) sig-
nalling pathway. This is causally related to ER stress since reactivation of ERK1/2 can pro-
tect cells from ER stress-induced apoptosis whilst ERK1/2 pathway inhibition sensitises
cells to ER stress. Furthermore, cancer cell lines harbouring constitutively active BRAFV600E
are addicted to ERK1/2 signalling for protection against ER stress-induced cell death.
ERK1/2 signalling normally represses the pro-death proteins BIM, BMF and PUMA and it
has been proposed that ER stress induces BIM-dependent cell death. We found no evi-
dence that ER stress increased the expression of these proteins; furthermore, BIM was not
required for ER stress-induced death. Rather, ER stress caused the PERK-dependent inhi-
bition of cap-dependent mRNA translation and the progressive loss of pro-survival proteins
including BCL2, BCLXL and MCL1. Despite these observations, neither ERK1/2 activation
nor loss of BAX/BAK could confer long-term clonogenic survival to cells exposed to ER
stress. Thus, ER stress induces cell death by at least two biochemically and genetically dis-
tinct pathways: a classical BAX/BAK-dependent apoptotic response that can be inhibited
by ERK1/2 signalling and an alternative ERK1/2- and BAX/BAK-independent cell death
pathway.
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Introduction
The endoplasmic reticulum (ER) is the site of modification, folding and maturation of trans-
membrane and secreted proteins and, as an intracellular Ca2+ store, plays a prominent role in
signal transduction. Increased demand for transmembrane and secreted proteins or perturba-
tions within the ER (e.g., reduced luminal [Ca2+] or altered redox status) undermines protein
processing in the ER resulting in the accumulation of misfolded proteins [1]. Such ‘ER stress’
elicits the ‘unfolded protein response’ (UPR) which acts to restore ER protein homeostasis by
shutting down general protein synthesis, cleaving mRNAs encoding membrane and secretory
proteins that would normally be trafficked through the ER and selectively driving the expres-
sion of chaperones such as BiP/GRP78 to enhance the protein folding capacity of the ER [2].
The UPR involves three key signalling cascades that are controlled by inositol requiring
protein 1 (IRE1), protein kinase R-like ER kinase (PERK) and activating transcription factor 6
(ATF6). PERK and IRE1 span the ER membrane, and contain a luminal domain that detects
misfolded polypeptides [3] to initiate signalling through their cytosolic domains. The cytosolic
kinase domain of PERK phosphorylates eukaryotic translation initiation factor 2α (eIF2α)
thereby inhibiting cap-dependent translation [4]; however, alternative translation initiation
mechanisms allow the continued synthesis of a subset of proteins such as the transcription fac-
tor ATF4 [5–8] which in turn drives the expression of stress-responsive genes including the
transcription factor CCAAT/enhancer-binding protein homologous protein (CHOP) [5].
IRE1 has both cytosolic protein kinase and endoribonuclease (RNase) domains; the kinase
domain activates the JNK signalling pathway [9], whereas the RNase domain promotes
destruction of ER-associated mRNAs through regulated IRE1-dependent decay (RIDD) [10,
11] and also promotes a non-canonical splicing event to generate the spliced form of transcrip-
tion factor X-box binding protein 1 (XBP1s) [12]. ATF6 is constitutively expressed in a latent
form but following ER stress is processed at the Golgi into an active form that translocates to
the nucleus to drive transcription [13].
If ER stress is too severe or persistent, including in certain pathological conditions, UPR
signalling can also drive apoptotic cell death [14]. Apoptosis is initiated through two major
pathways: the cell intrinsic, mitochondrial pathway, regulated by the BCL2 protein family and
the cell extrinsic, death-receptor pathway [15]; each pathway ultimately converges to activate
the executioner caspases such as caspase-3. There remains considerable debate about how
UPR signalling engages with these core apoptotic pathways. IRE1-dependent de-repression of
caspase-2 was proposed [16] but caspase-2 is not required for ER stress-induced apoptosis [17,
18]. In contrast, there is a prominent role for CHOP since CHOP-/- cells are protected from
ER stress [19, 20]. Other studies have suggested that ER stress initiates apoptosis via the intrin-
sic BCL2 pathway [14, 21]; indeed, it has been proposed that ER stress drives apoptosis thr-
ough the upregulation of the pro-apoptotic BH3-only protein BIM [22, 23], a response that is
mediated in part by CHOP. However, it has also been proposed that ER stress drives apoptosis
through the CHOP-dependent cell autonomous up-regulation and ligand-independent activa-
tion of the death receptor DR5 [17, 24]; how this relates to the BCL2 pathway is unclear.
Here we have investigated ER stress-induced death. We find that ER stress-induces BAX/
BAK-dependent apoptosis that can be rescued by ERK1/2 activation but we find no evidence
of a role for BIM; rather ER stress causes the PERK-dependent inhibition of mRNA translation
and loss of multiple pro-survival BCL2 proteins. Despite this, loss of BAX/BAK or strong
ERK1/2 activation fails to confer long-term survival following ER stress. Thus, ER stress
induces cell death by at least two alternative pathways: a BAX/BAK-dependent apoptotic
response that can be inhibited by ERK1/2 signalling and an alternative, ERK1/2- and BAX/
BAK-independent cell death pathway.
ERK1/2 signalling protects against ER stress-induced apoptosis
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Materials and methods
Materials
Thapsigargin was purchased from Invitrogen. Tunicamycin was purchased from Enzo Life Sci-
ences. 4-hydroxytamoxifen (4-HT) was purchased from Sigma; in all experiments involving
4-HT 0.1% ethanol, the diluent for 4-HT, was used and was without effect. Selumetinib
(AZD6244/ARRY-142886) and AZD8055 were provided by Paul Smith, AstraZeneca, Alderley
Park, Macclesfield, UK, whilst SCH772984 was purchased from Selleck Chemicals. ABT-263
was purchased from Santa Cruz Biotechnology. GSK2606414 and QVD-oPh were purchased
from MERCK and Calbiochem respectively. Antibodies specific for BCLXL (2762), BiP (3177),
CHOP (2895), eIF2α (9722), p-eIF2α (Ser51) (9721), p-ERK1/2 (Thr202/Tyr204) (9106),
IRE1α (3294), PARP (9542) and PERK (3192) were purchased from Cell Signaling Technol-
ogy; ERK1 (610031) from BD Biosciences; BIM (AB17003) from Millipore; BMF (ALX-804-
343) from Enzo Life Sciences; PUMA (3043) from ProSci; BAK (sc-832), BAX (sc-493), BCL2
(sc-7382) and MCL1 (sc-819) from Santa Cruz Biotechnology; Atg5 (A0731) and β-Actin
(A544) from Sigma. Horseradish peroxidase-conjugated secondary antibodies were from Bio-
Rad and the enhanced chemiluminescence (ECL) system from GE Healthcare was used for
detection.
Preparation of cell extracts and Western blotting
Cells were lysed in ice-cold TG lysis buffer, assayed for protein content and analysed by West-
ern blotting following fractionation by SDS-PAGE [25].
Flow cytometry
Propidium iodide staining and flow cytometry was used to determine the distribution of cells
in G1, S, G2/M and dead cells (sub-G1) [26].
RNA interference
Transient siRNA knockdown of BIM in COLO205 cells was performed as described previously
[27]. PERK siRNA (M-004883) and non-targeting siRNA (D-001206) were purchased from
Dharmacon. HCT116 cells were transfected using DharmaFECT solution 2 (Dharmacon) and
10 nM siRNA as per manufacturer’s instructions.
Colony formation assays
Cells were seeded at 200 cells per well in 12-well plates and left to settle for 24 h prior to treat-
ment as indicated. The medium was replaced with fresh medium each week during the assay,
cells were allowed to grow for 9–11 days including the treatment period. Subsequently cells
were fixed in 75% (v/v) methanol, 25% (v/v) acetic acid and stained with crystal violet. Colo-
nies were assessed either by measuring crystal violet absorbance following solubilisation in
10% (v/v) acetic acid or by counting.
Cell lines
COLO205 and HT29 cells were purchased from ATCC (Manassas, VA, USA). HCT116 cells
and isogenic derivatives were provided by Bert Vogelstein, John Hopkins University and Rich-
ard Yule, National Institute of Health, Bethesda. Atg5 WT and Atg5-/- immortalised mouse
embryonic fibroblasts (iMEFs) were provided by Noboru Mizushima, Tokyo Medical and
Dental University. NIH3T3 ΔCRAF:ER cells [28] were provided by Martin McMahon,
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University of California, San Francisco. Generation of CCL39 ΔCRAF:ER cells was described
previously [29]. Cells were cultured in medium comprising RPMI 1640 (COLO205 cells),
McCoy’s 5A (HT29 cells), Dulbecco’s modified Eagle’s medium (HCT116, iMEF and HEK293
cells) or Dulbecco’s modified Eagle’s medium without phenol red (NIH3T3 and CCL39 cells
expressing ΔCRAF:ER) supplemented with glucose (4.5 mg ml-1), penicillin (100 units ml-1),
streptomycin (100 μg ml-1), L-glutamine (1 mM), fetal bovine serum (10% v/v), puromycin
(6 μg ml-1; ΔCRAF:ER cell lines), blasticidin (5 μg ml-1; HEK293 TetR cell lines) and zeocin
(100 μg ml-1; HEK293 TetR EV and CHOP cell lines).
Generation of HEK293 TetR cell lines
HEK293 TetR cells were provided by Dr Anne Ashford, The Babraham Institute and were gen-
erated by transfection of HEK293 cells with pcDNA6/TR (Invitrogen). Plasmid DNA was
combined with 13.6 nM CaCl2 in HEPES-buffered saline and added dropwise to cells. Cells
were selected using 5 μg ml-1 blasticidin and were isolated from single cell clones. HEK293
TetR cells were then transfected with pcDNA4/TO (Invitrogen) or pcDNA4/TO Myc-CHOP
(human) and stably transfected cells were selected from single cell clones using 100 μg ml-1
zeocin.
Results
ERK1/2 signalling protects cells from ER stress-induced apoptosis
We investigated ER stress using two common ER stressors: thapsigargin (Tg), a sarco/endo-
plasmic reticulum Ca2+ ATPase (SERCA) inhibitor, depletes ER Ca2+, thereby undermining
the protein folding capacity of the ER, whereas tunicamycin (Tm) inhibits N-linked glycosyla-
tion, promoting the accumulation of misfolded proteins within the ER lumen. Treatment of
NIH3T3 fibroblasts with Tg or Tm resulted in a rapid expression of CHOP followed by the
delayed expression of BiP and IRE1; these are characteristic markers of ER stress and UPR sig-
nalling (Fig 1A). Similar results were seen in several different fibroblast cell lines including
iMEFs and CCL39 cells (see below) and in COLO205 colorectal cancer cells (S1A & S1B Fig).
Both Tm and Tg promoted cell death in NIH3T3 cells as judged by the appearance of cleaved
PARP (Fig 1B & S2A Fig) and by the appearance of cells with sub-G1 DNA (Fig 1C & S2B
Fig); similar results were observed in CCL39 fibroblasts (Fig 1C & S2B Fig).
In the course of our analysis we noted that both Tg and Tm caused a progressive inactiva-
tion of the extracellular signal-regulated kinases, ERK1/2, as judged by the reduction in phos-
phorylated ERK1/2 (p-ERK1/2). This was observed in NIH3T3 fibroblasts (Fig 1A), CCL39
fibroblasts and immortalised mouse embryo fibroblasts (iMEFs). Prompted by this we exam-
ined the consequences of restoring ERK1/2 signalling using ΔCRAF:ER, a conditional mutant
of CRAF that is activated by 4-hydroxytamoxifen (4HT) and drives MEK1/2-ERK1/2 signal-
ling [28]. Treatment of NIH3T3 ΔCRAF:ER cells with 4HT prevented the Tm-induced loss of
p-ERK1/2 and PARP cleavage (Fig 1B) and provided substantial protection against Tm-
induced cell death (Fig 1C). Activation of ΔCRAF:ER did not prevent the Tm-induced expres-
sion of CHOP (Fig 1B) indicating that ERK1/2 signalling did not reduce ER stress or inhibit
UPR signalling. Similar results were obtained in CCL39 ΔCRAF:ER cells [29] (Fig 1C) and
when Tg replaced Tm as the ER stressor (S2A & S2B Fig). The protective effect of 4HT treat-
ment was reversed by addition of selumetinib (AZD6244/ARRY-142886) [30] an allosteric
MEK1/2 inhibitor (S3A & S3B Fig) or the selective ERK1/2 inhibitor SCH772984 [31] (S3C &
S3D Fig). Furthermore, either selumetinib or SCH772984 increased Tg- and Tm-induced cell
death in NIH3T3 cells (S3B & S3D Fig) suggesting that ERK1/2 signalling normally limits ER
stress-induced cell death.
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Fig 1. Activation of ERK1/2 protects against ER stress-induced cell death. (A) NIH3T3 cells were
treated with either 100 nM Tg (left panel) or 2 μg ml-1 Tm (right panel) for the indicated time. Whole cell lysates
were separated by SDS-PAGE and analysed by immunoblotting using the indicated antibodies. (B) NIH3T3
ΔCRAF:ER cells were pre-treated for 1 h with 100 nM 4-HT prior to treatment with 2 μg ml-1 Tm for the
indicated time. Lysates were fractionated by SDS-PAGE and analysed by immunoblotting with the indicated
antibodies. Results in (A) and (B) are representative of 3 independent experiments. (C) NIH3T3 ΔCRAF:ER
(left panel) or CCL39 ΔCRAF:ER (right panel) cells were pre-treated for 1 h with 100 nM 4-HT before addition
of 2 μg ml-1 Tm for 48 h. Cells were then fixed, stained with propidium iodide and the proportion of cells with
sub-G1 DNA was measured by flow cytometry. Results are the means ± S.D. of 3 independent experiments
ERK1/2 signalling protects against ER stress-induced apoptosis
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In contrast to these fibroblast cell lines, COLO205 cells maintained p-ERK1/2 levels follow-
ing either Tg or Tm treatment (Fig 1D) and exhibited only a modest increase in cell death in
response to these treatments (Fig 1E). COLO205 cells possess an activating BRAFV600E muta-
tion and exhibit constitutive ERK1/2 signalling which could drive innate resistance to ER
stress. Indeed, whilst selumetinib caused little or no cell death when added to COLO205 cells
alone [27, 32] it inhibited constitutive ERK1/2 signalling (Fig 1D) and combined with Tg or
Tm to cause a striking increase in cell death (Fig 1E). Selumetinib also enhanced ER stress-
induced cell death in the BRAFV600E mutant colorectal cancer cell line, HT29 (S4 Fig). This
effect was smaller than that seen in COLO205 cells and probably reflects the presence in HT29
cells of an activating p110αP449T mutation in PIK3CA that may contribute MEK1/2-ERK1/2
independent survival signals; notably COLO205 cells exhibit wild type PIK3CA. Together with
the experiments using ΔCRAF:ER these results demonstrated in multiple cell lines that ER
stress-induced cell death is limited by the magnitude of ERK1/2 signalling and that ERK1/2
acts downstream or independently of canonical UPR signalling to protect cells.
ER stress drives caspase-dependent cell death that is dependent upon
BAX and BAK
To understand how ERK1/2 signalling protected against ER stress we first defined the cell
death response in detail using pharmacological and genetic interventions. Treatment of
HCT116 cells with Tg or Tm resulted in the same coordinate changes in expression of CHOP
and BiP (Fig 2A) and caused a striking increase in apoptosis as defined by the protective effect
of the pan-caspase inhibitor QVD-oPh (Fig 2B). It has been proposed that ER stress-induced
apoptosis proceeds by the cell intrinsic, mitochondrial pathway that is regulated by the BCL2
protein family [14, 21] but other studies have implicated death receptor signalling via DR5 [17,
24]. Using isogenic clones of HCT116 cells lacking either the BAX or BAK executioner pro-
teins (Fig 2C) we found that Tm-induced apoptosis was reduced by loss of BAX or BAK but
was almost completely abolished in BAX/BAK double knockout (DKO) cells (Fig 2D). These
isogenic clones exhibited normal expression of CHOP and BiP in response to Tm (Fig 2E), so
that defects in ER stress-induced death were not due to amelioration of ER stress or reduced
UPR signalling. BAX/BAK DKO cells were also protected against Tg-induced cell death (S5A
& S5B Fig). Together these results demonstrated that ER stress promoted caspase-dependent
apoptotic cell death that was dependent upon BAX and BAK.
ER stress fails to increase BIM expression but inhibits the expression of
multiple pro-survival proteins
ER stress is proposed to activate apoptosis by increasing expression of BIM, a pro-apoptotic
‘BH3 only protein’ (BOP) and part of the BCL2 protein family [22, 23]. Indeed, this was consis-
tent with prior observations that ERK1/2 signalling represses BIM [25, 33] and protects against
ER stress (Fig 1; S2 Fig). However, neither Tg nor Tm treatment increased the expression of
BIMEL, or BMF and PUMA, two other BOPs that are repressed by ERK1/2 signalling (Fig 3A)
each performed in technical triplicate. Statistics represent the results of Student’s unpaired t-tests; **,
p < 0.01; ***, p < 0.001. (D) COLO205 cells were treated for 24 h with 1 μM Selumetinib (Sel) in addition to
DMSO, 30 nM Tg or 0.5 μg ml-1 Tm. Whole cell lysates were fractionated by SDS-PAGE and analysed by
western blotting with the indicated antibodies. Results are representative of at least 3 independent
experiments. (E) COLO205 cells were treated for 48 h as in (D). Cells were fixed, stained with propidium
iodide and cell cycle distribution was determined by flow cytometry. Results are the means ± S.D. of an
experiment performed in technical triplicate and representative of 3 independent experiments.
https://doi.org/10.1371/journal.pone.0184907.g001
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Fig 2. ER stress induces BAK/BAX-dependent, apoptotic cell death. (A) HCT116 cells were treated
with 100 nM Tg (top panel) or 2 μg ml-1 Tm (bottom panel) for the indicated time, whole cell lysates were
fractionated by SDS-PAGE and analysed by immunoblotting with the indicated antibodies. Results are
representative of at least 3 independent experiments. (B) HCT116 cells were treated with 100 nM Tg in the
presence or absence of 10 μM QVD-oPh for 48 h, fixed, stained with propidium iodide and the proportion of
cells with sub-G1 DNA was measured by flow cytometry. Results are the means ± S.D. of 3 experiments each
performed in technical triplicate. Student’s unpaired t-test results are indicated as follows; ***, p < 0.001. (C)
Whole cell lysates of HCT116, HCT116 BAK-/-, HCT116 BAX-/- or HCT116 BAK-/-, BAX-/- (DKO) cells were
separated by SDS-PAGE and immunoblotted with the indicated antibodies to confirm their genotype. (D)
HCT116, HCT116 BAK-/-, HCT116 BAX-/- or HCT116 BAK-/-, BAX-/- (DKO) cells were treated with 2 μg ml-1
Tm for 48 h, fixed, stained with propidium iodide and the proportion of cells with sub-G1 DNA was measured
ERK1/2 signalling protects against ER stress-induced apoptosis
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[27]. In contrast, selumetinib treatment increased the expression of BIMEL, BMF and PUMA
and promoted the de-phosphorylation of BIMEL (Fig 3A) indicating that we could detect
dynamic changes in these proteins under appropriate conditions. Whilst there were no
changes in BIM abundance, BIM could be activated by post-translational mechanisms [33]
and contribute to apoptosis so we used RNA interference to investigate if BIM was required for
ER stress-induced apoptosis. Despite very strong knock down (Fig 3B), BIM siRNA had no
effect on Tg- or Tm-induced death in COLO205 cells (Fig 3C). As a control, BIM siRNA inhib-
ited cell death induced by the combination of selumetinib and the BH3-mimetic ABT-263 (SA)
by up to 50% (Fig 3C) confirming previous observations [27] and demonstrating that our assays
were appropriate to detect BIM-dependent apoptosis. BIM induction by ER stress is proposed
to be mediated by CHOP so we generated a HEK293 cell line that exhibited tetracycline-depen-
dent expression of Myc-tagged CHOP (S6A Fig). This construct was functional since it pro-
moted the expression of endogenous CHOP [34] (S6A Fig); however, Myc-CHOP failed to
increase BIM levels (S6B Fig), even when its expression was combined with ER stress which
might activate co-factors or promote required post-translational modifications [22, 35, 36].
The cell-intrinsic pathway of apoptosis can be initiated by the expression/activation of
BH3-only proteins or the repression/inactivation of pro-survival BCL2 proteins [15]. Indeed,
we found that Tg and Tm both promoted a time- and dose-dependent reduction in the expres-
sion of multiple pro-survival proteins including BCL2, BCLXL and MCL1, over the same dose
range at which they induced BiP expression (Fig 3D & 3E; S7A Fig). The reduction in MCL1
and BCL2 expression was apparent within 4–8 hours of Tg or Tm treatment, prior to any evi-
dence of caspase activation as judged by PARP cleavage (Fig 3D & 3E). However, at 24 hrs
when PARP cleavage was apparent the inclusion of the pan-caspase inhibitor QVD-oPh
reversed some of the reduction in MCL1, BCLXL and BCL2 expression and this effect was
more apparent after 48 hours (S7B Fig). These results suggest that the early loss of pro-survival
proteins is largely independent of caspase activation but caspase-dependent cleavage may
make a progressively greater contribution at later times as the cells are dying. Notably, activa-
tion of ΔCRAF:ER-MEK1/2-ERK1/2 delayed or reduced the loss of BCLXL and MCL1 (Fig 3D
& 3E), even at early time points prior to PARP cleavage, correlating with the increased survival
effects of ERK1/2 signalling described above (Fig 1C; S2B Fig). Together, these results demon-
strated that ER stress failed to increase expression of BIM (or BMF and PUMA) and that BIM
was not required for ER stress-induced death. Rather, ER stress reduced the expression of mul-
tiple pro-survival BCL2 proteins, three of which (BCL2, BCLXL and MCL1) are known to be
regulated by ERK1/2-dependent survival signalling [37].
ER stress causes the PERK-dependent inhibition of translation and loss
of pro-survival BCL2 proteins
ER stress inhibits global mRNA translation by PERK-dependent phosphorylation of eIF2α;
this inhibits recruitment of the ribosome to the mRNA-bound pre-initiation complex. How-
ever, translation of the ATF4 transcription factor proceeds efficiently despite this due to a
series of short upstream open reading frames within the ATF4 50 UTR [7, 8] allowing ATF4 to
drive the expression of target genes including CHOP. Following Tg or Tm treatment, PERK
by flow cytometry. Results are the means ± S.D. of 3 independent experiments each performed in technical
triplicate. Statistics represent the results of two-way ANOVA and Bonferroni post-tests comparing each
genotype to WT; ***, p < 0.001. (E) HCT116, HCT116 BAK-/-, HCT116 BAX-/- or HCT116 BAK-/-, BAX-/-
(DKO) cells were treated with 2 μg ml-1 Tm for 4 h (top panel) or 24 h (bottom panel). Whole cell lysates were
separated by SDS-PAGE and analysed by immunoblotting with the indicated antibodies. Results are
representative of three independent experiments.
https://doi.org/10.1371/journal.pone.0184907.g002
ERK1/2 signalling protects against ER stress-induced apoptosis
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Fig 3. ER stress-induced apoptosis does not require BIM but is accompanied by loss of multiple pro-
survival proteins. (A) HCT116 cells were treated with 1 μM Selumetinib (Sel) or the indicated concentration
of Tg (left panel) or Tm (right panel) for 24 h, whole cell lysates were then separated by SDS-PAGE and
analysed by immunoblotting with the indicated antibodies. Results are representative of 3 independent
experiments. (B) COLO205 cells were transfected with non-targeting (NT) or BIM-specific (siBIM) siRNA or
left untransfected (UT). At 48 h post-transfection cells were treated with 100 nM Tg, 2 μg ml-1 Tm or with 1 μM
Selumetinib + 200nM ABT-263 (SA) for a further 24 h. Whole cell lysates were fractionated by SDS-PAGE
and analysed by immunoblotting with the indicated antibodies. Results are representative of at least 3
independent experiments. (C) COLO205 cells were transfected and treated for 48 h as described in (B), fixed,
stained with propidium iodide and the proportion of cells with sub-G1 DNA was measured by flow cytometry.
ERK1/2 signalling protects against ER stress-induced apoptosis
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was autophosphorylated from 2 h onwards as determined by band-shift, although there were
subtle differences in the effects of these different ER stressors after 8 h (S8A Fig), consistent
with previous reports [38]. To assess whether the loss of MCL1 following ER stress was a result
of this PERK-dependent pathway we used GSK2606414, a novel, potent and highly selective
inhibitor of the PERK kinase domain [39]. The efficacy and selectivity of GSK2606414 was
confirmed by showing that it inhibited Tg-induced PERK auto-phosphorylation and CHOP
expression, but failed to inhibit BiP expression even at 100 nM, a dose that abolished CHOP
expression (Fig 4A). This is consistent with BiP being a target of ATF6 signalling [40] and indi-
cates that IRE1 and ATF6 signalling are sufficient to maintain induction of BiP in these cells.
To assess the efficacy of GSK2606414 we employed a bicistronic dual Renilla–Firefly luciferase
reporter construct (pRL-IRES-FL) which directs cap-dependent translation of the Renilla lucif-
erase gene and cap-independent, polio IRES (polIRES)-mediated translation of the firefly lucif-
erase gene [41,42]. Indeed, Tm treatment reduced the cap/IRES-dependent translation ratio,
to a similar extent as that observed with the mTOR kinase inhibitor AZD8055, and this was
completely reversed by the PERK inhibitor GSK2606414 (Fig 4B).
We then used GSK2606414 to investigate the role of PERK in the loss of MCL1. These
experiments involved a 24 hour treatment with Tm during which PERK expression actually
declined so that the hyper-phosphorylated forms of PERK were not readily visible, unlike
with Tg treatment, where PERK levels recovered at 8 and 24 hours (S8A Fig); nonetheless
GSK2606414 completely prevented this loss of PERK. Tm again caused a dose-dependent loss
of expression of MCL1 and also cyclin D1, both encoded by mRNAs that undergo cap-depen-
dent translation. GSK2606414 completely prevented the Tm-induced loss of cyclin D1 and
MCL1 (Fig 4C) and also completely prevented the Tg-induced loss of MCL1 (Fig 4A) suggest-
ing that this was due to PERK-dependent inhibition of translation. Thus ER stress acts through
PERK to inhibit cap-dependent protein translation, including that of pro-survival proteins
such as MCL1.
Despite sustaining pro-survival protein levels, PERK inhibition enhances
ER stress-induced death
Although inhibition of PERK could sustain MCL1 levels we found that treatment with GSK
2606414 actually promoted Tm-induced cell death (Fig 5A). Control blots confirmed that
treatment with GSK2606414 inhibited PERK-dependent induction of ATF4 and CHOP, with-
out affecting the later induction of BiP (Fig 5B). Similarly, GSK2606414 treatment enhanced
Tg-induced cell death and this was inhibited by QVD-oPh (S8B Fig). The increase in Tm-
induced cell death following PERK inhibition was still BAK/BAX-dependent (Fig 5C) and cas-
pase-dependent (Fig 5D). To verify these results were due to PERK inhibition, PERK targeting
siRNA was used and abolished PERK-dependent eIF2α phosphorylation without affecting
Tm-induced BiP levels (Fig 6A). Consistent with the results using GSK2606414, PERK knock-
down enhanced Tm-induced cell death and this was inhibited by addition of QVD-oPh (Fig
6B). Therefore despite maintenance of MCL1 levels, chemical or genetic PERK inhibition
promoted caspase- and BAK/BAX-dependent cell death following ER stress demonstrating
that PERK acts as a pro-survival pathway during ER stress. Finally, activation of ΔCRAF:
Results are the means ± S.D. of 3 independent experiments each performed in technical triplicate, and
statistics represent the results of Student’s unpaired t-tests; N.S., not significant; **, p < 0.01. (D & E) CCL39
ΔCRAF:ER cells were pre-treated for 1 h with 100 nM 4-HT prior to the addition of 2 μg ml-1 Tm (D) or 100 nM
Tg (E) for the indicated time. Whole cell lysates were fractionated by SDS-PAGE and were transferred to
immunoblot before analysis with the indicated antibodies. Results are representative of 3 independent
experiments.
https://doi.org/10.1371/journal.pone.0184907.g003
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ER-MEK1/2-ERK1/2 signalling not only protected against Tm, but was also able to protect
against the enhanced cell death arising from Tm+GSK2606414 (Fig 7A & 7B). Thus PERK pro-
tects against Tm-induced death and PERK inhibition further enhances cell death through a
pathway that is also inhibitable by ERK1/2 signalling, establishing that ERK1/2 activation can
protect against cell death arising from PERK inhibition.
ER stress induces ERK1/2-regulated, BAK/BAX-dependent apoptosis
and a distinct ERK1/2- and BAK/BAX-independent cell death pathway
In previous studies, BAK/BAX DKO cells were not protected against prolonged ER stress [43].
Indeed, despite significant protection in short-term (48 hour) assays for apoptosis (Fig 2D;
S5A Fig), BAK/BAX DKO cells were not protected against either Tm- or Tg-induced cell
death in a long-term clonogenic assay (S9A Fig); similarly caspase inhibition did not promote
long-term clonogenic survival of HCT116 cells against ER stress (S9B Fig). Finally, mainte-
nance of ERK1/2 activity in NIH3T3 and CCL39 cells using ΔCRAF:ER prevented ER stress-
induced apoptosis (Fig 1C; S2B Fig), but did not confer long-term cell survival (S9C Fig). Thus
in addition to apoptosis, ER stress also induced a BAK/BAX-independent pathway of cell
death, which was not inhibited by ERK1/2 activation.
Autophagy has been proposed to promote both cell survival and cell death in response to ER
stress [44], hence autophagy deficient (Atg5-/-) iMEFs were used to determine the role of autop-
hagy following ER stress. Treatment with either ER stressors again decreased P-ERK1/2 and
induced a greater proportion of cell death in Atg5-/- iMEFs compared to WT iMEFs, though this
effect was more pronounced for Tg treatment (Fig 8A; S10A Fig). Control blots demonstrated
that Atg5-/- iMEFs exhibited normal expression of the UPR markers, CHOP and BiP, following
treatment with an ER stressor (Fig 8B; S10B Fig), so the increase in ER stress-induced cell death
was not due to greater activation of UPR signalling. Therefore, induction of autophagy promoted
cell survival and did not contribute to the alternative cell death pathway following ER stress.
Discussion
Following ER stress, activation of the UPR leads to one of two outcomes; cell survival and
adaptation, or cell death. There is a growing interest in engaging or selectively inhibiting one
of these outcomes to manipulate the ER stress response as a therapeutic approach for certain
disease indications [9, 45]. Here we investigated the role of the ERK1/2 signalling pathway in
the cell death response induced by ER stress.
ERK1/2 signalling limits ER stress-induced apoptosis
This study was prompted by the observation that Tg or Tm led to a progressive inactivation of
ERK1/2 in several different fibroblast cell lines (Fig 1A and 1B; Fig 3D and 3E; Fig 8B; S10B Fig).
Fig 4. ER stress-induced inhibition of cap-dependent translation and loss of MCL1 is PERK-
dependent. (A) HCT116 cells were pre-treated for 1 h with the indicated concentration of GSK2606414
before addition of 100 nM Tg for 6 h. Whole cell lysates were separated by SDS-PAGE and analysed by
immunoblotting using the indicated antibodies. (B) HCT116 cells were transfected with a dual luciferase
reporter construct for assay of CAP/IRES-dependent translation. 24 h post-transfection, cells were pre-
treated for 1 h with 100 nM GSK2606414 (GSK) before addition of 2 μg ml-1 Tm or 1 μM AZD8055 for 24 h.
Results shown are the mean ± S.D. luciferase activity within the whole cell lysates of one experiment
performed in technical triplicate and are representative of three independent experiments. Statistics shown
are the results of Student’s unpaired t-tests; N.S., not significant; *, p < 0.05. (C) HCT116 cells were pre-
treated for 1 h with 100 nM GSK2606414 prior to the addition of the indicated concentration of Tm for 24 h.
Whole cell lysates were fractionated by SDS-PAGE and analysed by immunoblotting using the indicated
antibodies. Results in (A) and (C) are representative of 3 independent experiments.
https://doi.org/10.1371/journal.pone.0184907.g004
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Fig 5. The PERK inhibitor GSK2606414 exacerbates ER stress-induced apoptosis. (A) HCT116 cells
were pre-treated for 1 h with 100 nM GSK2606414 prior to addition of the indicated concentration of Tm for 48
h. Cells were fixed, stained with propidium iodide and the proportion of cells with sub-G1 DNA was measured
by flow cytometry. Results shown are the means ± S.D. of 3 independent experiments each performed in
technical triplicate. Statistics represent the results of two-way ANOVA and Bonferroni post-tests; ***,
p < 0.001. (B) HCT116 cells were treated as in (A) for 6 h (top panel) or 24 h (bottom panel). Whole cell
lysates were analysed by immunoblotting using the indicated antibodies following separation by SDS-PAGE.
Results shown are representative of 3 independent experiments. (C) HCT116 and HCT116 BAK-/-, BAX-/-
(DKO) cells were pre-treated for 1 h with 100 nM GSK2606414 (GSK) before 48 h treatment with 0.1 μg ml-1
Tm. Cells were fixed, stained with propidium iodide and the proportion of cells with sub-G1 DNA was
measured by flow cytometry. (D) HCT116 cells were pre-treated for 1 h with 100nM GSK2606414 prior to
addition of 0.1 μg ml-1 Tm and 10 μM QVD-oPh (QVD), as indicated, for 48 h. Cells were fixed, stained with
propidium iodide and the proportion of cells with sub-G1 DNA was measured by flow cytometry. Results
shown in (C) and (D) are the means ± S.D. of 3 independent experiments performed in technical triplicate.
Statistics represent the results of Student’s unpaired t-tests; **, p < 0.01.
https://doi.org/10.1371/journal.pone.0184907.g005
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This inactivation of ERK1/2 could be due to the induced expression of the dual specificity phos-
phatase (DUSP) enzymes that de-phosphorylate ERK1/2 [46]. However, ER stress did not inhibit
ERK1/2 activation by ΔCRAF:ER (Fig 1B; S2A Fig); nor did it inhibit ERK1/2 in colorectal can-
cer cells with constitutively active BRAFV600E (Fig 1D; S1 Fig). This suggests that the core RAF-
MEK1/2-ERK1/2 pathway is largely unaffected and the loss of ERK1/2 activation following ER
stress may be the result of decreased stimulation of the pathway upstream of RAF. This could
arise through the expression of feedback regulators of the pathway such as sprouty (SPRY)/
SPRY-related (SPRED) proteins that act at the level of receptors or RAS. Alternatively, many of
the growth factors and cytokines that activate ERK1/2 signalling are trafficked through the ER
and are sensitive to conditions within the ER lumen. Whilst there is a reduction in the luminal
protein load in response to ER stress, there is also an increase in the secretion of pro-inflamma-
tory cytokines [47–49]. So although ER stress does not induce a widespread loss of extracellular
factors, it may promote a change in the secretion profile, perhaps favouring pro-inflammatory
signalling (JNK, p38, NFκB) over ERK1/2 signalling. In addition, ER stress may also affect the
synthesis, maturation and trafficking of the cell surface receptors for these growth factors and
cytokines. For example, the ER luminal chaperone protein, BiP, which is induced in response to
ER stress, inhibits the maturation of epidermal growth factor receptor (EGFR), promoting its
retention within the ER and decreasing activation of downstream signalling pathways [50],
including ERK1/2 signalling.
Whilst future studies should aim to define how ER stress impairs ERK1/2 signalling, our
results indicate that ERK1/2 signalling is a key determinant of ER stress-induced apoptosis
based on three key observations: (i) activation of ERK1/2 by ΔCRAF:ER protected cells from
apoptosis; (ii) the MEK1/2 inhibitor selumetinib or the ERK1/2 inhibitor SCH772984
Fig 6. RNAi-mediated silencing of PERK exacerbates ER stress-induced apoptosis. (A) HCT116 cells
were untransfected (UT) or transfected with non-targeting (NT) or PERK-targeting (siPERK) siRNA for 48 h
prior to treatment with 0.1 μg ml-1 Tm and 10 μM QVD-oPh (Q) for 24 h. Whole cell lysates were fractionated by
SDS-PAGE and analysed by immunoblotting using the indicated antibodies. Results shown are representative
of three independent experiments. (B) HCT116 cells were transfected for 48 h as in (A) prior to treatment for 48
h with 0.1 μg ml-1 Tm and 10 μM QVD-oPh (QVD). Cells were fixed, stained with propidium iodide and the
proportion of cells with sub-G1 DNA was measured by flow cytometry. Results are the combined means ± S.D.
of three independent experiments performed in technical triplicate. Statistics represent the results of Student’s
unpaired t-tests; *, p < 0.05.
https://doi.org/10.1371/journal.pone.0184907.g006
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enhanced apoptosis induced by ER stress in fibroblasts and (iii) tumour cells with BRAFV600E
exhibited constitutive ERK1/2 signalling and MEK1/2-dependent resistance to ER stress.
These results clearly demonstrate that ERK1/2 signalling normally limits the extent of ER
stress-induced death in a variety of cell types and adds to growing evidence that this aspect of
ERK1/2 survival signalling is co-opted by tumour cells; for example, MEK1/2 inhibition sensi-
tises melanoma cells to ER stress-induced cell death [51]. Taken together with other studies
[52,53], these results suggest that combining ERK1/2 pathway inhibitors with ER stressors, or
ER stress mimetics that influence specific arms of the UPR, may have therapeutic potential in
tumours with RAS, BRAF or MEK mutations [9]. By extension, ERK1/2 inhibition may influ-
ence responses to UPR inhibitors in other disease states characterised by ER stress [9].
ER stress-induced apoptosis requires BAX/BAK but not BIM
Although ER stress has recently been proposed to induce apoptosis via activation of the DR5
death receptor [17, 24], it is unclear how this fits with prior reports of ER stress inducing BAK/
BAX-dependent cell death [43] via increased BIM expression [22, 23]. Since BIM is a well-
known target of ERK1/2 signalling [25,33,37] we anticipated that this would account for the
cytoprotective effects of ERK1/2 during ER stress. However, whilst we found that ER stress-
induced cell death was BAK/BAX-dependent (Fig 2D & S5 Fig), confirming dependence upon
the intrinsic apoptotic pathway, we found no evidence for the involvement of BIM (Fig 3); ER
stress did not increase BIM expression and BIM was not required for ER stress-induced apo-
ptosis. We also examined BMF and PUMA, additional BOPs that are ERK1/2 targets [27], but
again found no evidence that they were regulated by ER stress. Thus, engagement of BOPs is
Fig 7. Activation of ERK1/2 protects against cell death arising from PERK inhibition. (A) NIH3T3
ΔCRAF:ER cells were pre-treated with 100 nM 4-HT for 1 h before addition of 100 nM GSK2606414 (GSK)
and 0.1 μg ml-1 Tm alone or in combination as indicated for 24 h. Whole cell lysates were fractionated by
SDS-PAGE and analysed by immunoblotting using the indicated antibodies. Results are representative of two
independent experiments. (B) NIH3T3 ΔCRAF:ER cells were pre-treated with 100 nM 4-HT for 1 h before
addition of 100 nM GSK2606414 (GSK) and 0.1 μg ml-1 Tm alone or in combination as indicated for 48 h.
Cells were fixed and analysed by flow cytometry following propidium iodide staining. Results are means ± S.
D. of three technical replicates from a single experiment and are representative of two independent
experiments.
https://doi.org/10.1371/journal.pone.0184907.g007
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not a universal response to ER stress but rather depends on the cell type or perhaps the nature
of the ER stressor [22, 54].
In addition to repressing BOPs, ERK1/2 signalling can promote survival by increasing the
abundance of pro-survival BCL2 proteins [55]; for example, ERK1/2 signalling increases the
transcription of MCL1 and BCLXL and stabilizes the MCL1 protein [36,56–59]. We found that
ER stress reduced the expression of multiple pro-survival BCL2 proteins including MCL1,
BCL2 and BCLXL and this was apparent at early time points prior to caspase activation (Fig 3D
& 3E). In the case of MCL1 this was due to the PERK-dependent shut down of cap-dependent
translation providing a tangible link to ER stress and the UPR; a link that we failed to detect
for BIM, BMF or PUMA. Re-activation of ERK1/2 using ΔCRAF:ER, which prevents ER
stress-induced apoptosis, was also able to sustain expression of MCL1, BCL2 and BCLXL (Fig
3D & 3E). Indeed, ERK-dependent up-regulation of MCL1 has been proposed to account for
the resistance of some melanoma cells to ER stress [60]. Taken together these results suggest
that whilst ER stress-induced apoptosis is BAX/BAK-dependent it can proceed through the
loss of pro-survival BCL2 proteins rather than the induction of pro-apoptotic BOPs such as
BIM, BMF or PUMA.
PERK inhibition enhances ER stress-induced cell death
The loss of MCL1 expression following ER stress was due to the PERK-dependent inhibition
of cap-dependent translation (Fig 4); indeed, MCL1 is encoded by a cap-dependent transcript
[61]. However, whilst chemical or genetic inhibition of PERK maintained the levels of MCL1,
this did not protect against ER stress. Rather, chemical inhibition or genetic knockdown of
PERK promoted BAX/BAK-dependent apoptosis (Figs 5 & 6) demonstrating that PERK nor-
mally functions to promote survival in the face of ER stress. It is known that inhibition of
Fig 8. Atg5-/- immortalised MEFs exhibit enhanced ER stress-induced cell death. (A) Atg5 WT and
Atg5-/- iMEFs were treated with the indicated concentration of Tg for 48 h. Cells were fixed and analysed by
flow cytometry following propidium iodide staining. Results are the means ± S.D. of 3 independent experiments
performed in technical triplicate. Statistics represent the results of two-way ANOVA followed by Bonferroni
post-tests; **, p < 0.01; ***, p < 0.001. (B) Alternatively Atg5 WT and Atg5-/- iMEFs were treated as in (A) for
24 h. Whole cell lysates were fractionated by SDS-PAGE prior to analysis by immunoblotting using the
indicated antibodies. Results shown are representative of 3 independent experiments.
https://doi.org/10.1371/journal.pone.0184907.g008
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translation is critical in reducing the ER protein load following ER stress [62]; indeed, PERK-/-
cells are more sensitive to ER stress than WT cells [5, 62] presumably because PERK inhibition
during ER stress sustains high levels of protein synthesis, thereby further exacerbating ER
stress. ER stress in PERK-/- iMEFs has been proposed to promote oxidative stress and expres-
sion of the BH3-only protein NOXA to drive apoptosis [63]. In the context of our study this is
an attractive hypothesis since NOXA is the only selective MCL1 antagonist within the BOP
division of BCL2 proteins. A recent study proposed that PERK signalling represses the caspase
inhibitor XIAP [64], which in combination with the loss of pro-survival proteins shown here
may sensitise the cell to apoptosis, but it is unclear how this would relate to ERK1/2-dependent
protection against ER stress. However, whilst inhibition of apoptosis (loss of BAX/BAK or cas-
pase inhibition) protected cells against combined ER stress and PERK inhibition in short-term
assays (Fig 5) it could not provide protection in long-term clonogenic assays (S9A & S9B Fig).
Similarly, whilst activation of ERK1/2 signalling by ΔCRAF:ER prevented apoptosis arising
from ER stress (Fig 1) or ER stress and PERK inhibition (Fig 7), it could not confer long-term
protection, implying an alternative cell death pathway (S9C Fig).
Analysis of Atg5-/- fibroblasts argued against autophagy contributing to cell death; rather,
autophagy-deficient Atg5-/- fibroblasts exhibited enhanced cell death suggesting that autop-
hagy normally protects against ER stress, presumably by providing an alternative pathway for
the removal of misfolded or damaged proteins. ER stress has been proposed to induce ATP
depletion and necrotic cell death in cells deficient in BAX and BAK [65]; indeed, cells can
switch between apoptosis and necroptosis when one or other cell death modality is inhibited
[66]. Our own results are consistent with these reports and suggest that ER stress induces cell
death by at least two biochemically and genetically distinct pathways: a classical BAX/BAK-
dependent apoptotic response that can be inhibited by ERK1/2 signalling and an alternative,
ERK1/2- and BAX/BAK-independent necrotic response. In addition, chronic ER stress may
drive an irreversible cell cycle arrest and senescence and this may account for the strong reduc-
tion in clonogenic growth in BAX/BAK DKO cells. Indeed, persistent ERK1/2 signalling can
drive senescence in primary cells [67] and cell cycle arrest in immortalised cells [28] this may
explain why ERK1/2 activation by ΔCRAF:ER could not rescue the decline in clonogenicity
following ER stress. Regardless, the finding that ER stress can switch between ERK1/2-regu-
lated and ERK1/2-independent cell death pathways may be relevant to attempts to target ER
stress signalling in certain pathologies.
Supporting information
S1 Fig. ER stress does not decrease P-ERK1/2 in COLO205 cells. (A & B) COLO205 cells
were treated for the indicated time with 100 nM Tg (A) or 2 μg ml-1 Tm (B), and whole cell
lysates were analysed by immunoblotting using the indicated antibodies following fraction-
ation by SDS-PAGE. Results are representative of three independent experiments.
(TIF)
S2 Fig. Activation of ΔCRAF:ER protects against Tg-induced cell death. (A) NIH3T3
ΔCRAF:ER cells were treated for 1 h with 100 nM 4-HT, prior to addition of 100 nM Tg for
the indicated time. Whole cell lysates were fractionated by SDS-PAGE and analysed by immu-
noblotting using the indicated antibodies. Results shown are representative of three indepen-
dent experiments. (B) NIH3T3 ΔCRAF:ER (left panel) or CCL39 ΔCRAF:ER (right panel)
cells were pre-treated for 1 h with 100 nM 4-HT before addition of 100 nM Tg for 48 h. Cells
were then fixed, stained with propidium iodide and cell cycle distribution was measured by
flow cytometry. Results are the means ± S.D. from at least 3 independent experiments each
performed in technical triplicate. Student’s unpaired t-test results are indicated as follows; ,
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p< 0.001.
(TIF)
S3 Fig. Protection against ER stress afforded by ΔCRAF:ER is dependent on MEK1/2 and
ERK1/2. (A) NIH3T3 ΔCRAF:ER cells were pre-treated for 1 h with 100 nM 4-HT or 3 μM
Selumetinib (Sel), prior to addition of DMSO, 100 nM Tg or 2 μg ml-1 Tm for 24 h. Whole cell
lysates were analysed by immunoblotting using the indicated antibodies following fraction-
ation by SDS-PAGE. Results shown are representative of two independent experiments. (B)
NIH3T3 ΔCRAF:ER cells were pre-treated for 1 h with 100 nM 4-HT or 3 μM Selumetinib
(Sel), prior to addition of DMSO, 100 nM Tg or 2 μg ml-1 Tm for 48 h. Cells were fixed, stained
with propidium iodide and analysed by flow cytometry. Results shown are means ± S.D. of a
single experiment performed in technical triplicate and representative of two independent
experiments. Statistics represent the results of Student’s unpaired t-tests; , p< 0.01; ,
p< 0.001. (C) NIH3T3 ΔCRAF:ER cells were pre-treated for 1 h with 100 nM 4-HT or 100
nM SCH772984 (SCH), prior to addition of DMSO, 100 nM Tg or 2 μg ml-1 Tm for 24 h.
Whole cell lysates were analysed by immunoblotting using the indicated antibodies following
fractionation by SDS-PAGE. Results shown are representative of two independent experi-
ments. (D) NIH3T3 ΔCRAF:ER cells were pre-treated for 1 h with 100 nM 4-HT or 100 nM
SCH772984 (SCH), prior to addition of DMSO, 100 nM Tg or 2 μg ml-1 Tm for 48 h. Cells
were fixed, stained with propidium iodide and analysed by flow cytometry. Results shown are
means ± S.D. of a single experiment performed in technical triplicate and representative of
two independent experiments. Statistics represent the results of Student’s unpaired t-tests; ,
p< 0.01; , p< 0.001.
(TIF)
S4 Fig. MEK1/2-ERK1/2 signalling limits the extent of ER-stress induced cell death in
HT29 cells. (A) HT29 cells were treated for 24 h with 1 μM Selumetinib (Sel) in addition to
either DMSO or 30 nM Tg. Whole cell lysates were separated by SDS-PAGE and analysed by
immunoblotting using the indicated antibodies. Results shown are representative of three
independent experiments. (B) HT29 cells were treated as in (A) for 48 h, cells were fixed and
stained with propidium iodide prior to analysis by flow cytometry. (C) HT29 cells were treated
with 1 μM Selumetinib (Sel) and DMSO or 0.5 μg ml-1 Tm. Whole cell lysates were analysed
by immunoblotting using the indicated antibodies following fractionation by SDS-PAGE.
Results are representative of three independent experiments. (D) HT29 cells were treated for
48 h as described in (C), cells were fixed, stained with propidium iodide and analysed by flow
cytometry. Results shown in (B) and (D) are means ± S.D. of a single experiment performed in
technical triplicate and representative of three independent experiments. Statistics represent
the results of Student’s unpaired t-tests; , p< 0.01.
(TIF)
S5 Fig. Tg-induced cell death in BAX/BAK dependent. (A) HCT116, HCT116 BAK-/-,
HCT116 BAX-/- or HCT116 BAK-/-, BAX-/- (DKO) cells were treated with 100 nM Tg for 48 h.
Cells were fixed and analysed by flow cytometry following propidium iodide staining. Results
are means ± S.D. of three independent experiments performed in technical triplicate. Statistics
represent the results of two-way ANOVA and Bonferroni post-tests comparing each genotype
to WT; N.S., not significant; , p< 0.001. (B) HCT116, HCT116 BAK-/-, HCT116 BAX-/- or
HCT116 BAK-/-, BAX-/- (DKO) cells were treated with 100 nM Tg for 4 h (top panel) or 24 h
(bottom panel). Whole cell lysates were separated by SDS-PAGE and analysed by immuno-
blotting with the indicated antibodies. Results are representative of three independent
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experiments.
(TIF)
S6 Fig. CHOP fails to induce BIM expression even when combined with ER stress. (A)
HEK293 TetR cells stably transfected with pcDNA4/TO (EV) or pcDNA4/TO Myc-CHOP
were treated for 4 h with 1 μg ml-1 tetracycline (Tet), 100 nM Tg or 2 μg ml-1 Tm. Whole cell
lysates were analysed by immunoblotting following separation by SDS-PAGE. (B) Cell lines
detailed in (A) were pre-treated for 2 h with 1 μg ml-1 tetracycline (Tet) followed by addition
of 2 μg ml-1 Tm. Whole cell lysates were fractionated by SDS-PAGE and analysed by immuno-
blotting using the indicated antibodies. Results in (A) and (B) are from a single experiment,
with comparable results detected in two inducible CHOP cell lines.
(TIF)
S7 Fig. Loss of pro-survival BCL2 proteins upon ER stress and the effect of caspase inhibi-
tion. (A) COLO205 cells were treated with either Tg or Tm for 24 h. Whole cell lysates were
fractionated by SDS-PAGE and analysed by immunoblotting using the indicated antibodies.
Results shown are representative of three independent experiments. (B) HCT116 cells were
pre-treated for 1 h with vehicle (C) or 10 μM QVD-oPH (Q) followed by 100 nM Tg or 2 μg
ml-1 Tm for 24 or 48 h. Whole cell lysates were fractionated by SDS-PAGE and analysed by
immunoblotting using the indicated antibodies. Results are representative of three indepen-
dent experiments.
(TIF)
S8 Fig. PERK inhibition enhances Tg-induced apoptosis. (A) HCT116 cells were treated
with 100 nM Tg or 2 μg ml-1 Tm for the indicated times. Whole cell lysates were fractionated
by SDS-PAGE and analysed by immunoblotting using the indicated antibodies. Results are
from a single experiment. (B) HCT116 cells were pre-treated for 1 h with 100 nM GSK260
6414 prior to addition of 10 nM Tg and 10 μM QVD-oPh (QVD) for 48 h. Cells were fixed
and analysed by flow cytometry following propidium iodide staining. Results shown are the
means ± S.D. for a single experiment, representative of two independent experiments per-
formed in technical triplicate. Statistics represent the results of Student’s unpaired t-tests;
, p < 0.01.
(TIF)
S9 Fig. Inhibition of apoptosis or activation of ΔCRAF:ER fails to confer long term protec-
tion against ER stress. (A) HCT116 or HCT116 BAK-/-, BAX-/- (DKO) cells were treated for
72 h with 100 nM Tg (left panel) or 2 μg ml-1 Tm (right panel), treatment media was then
removed and colonies were left to grow for 7 days. Cells were then fixed, stained with crystal
violet and colonies with a diameter greater than approximately 0.2 mm were counted. Results
shown are the combined means ± S.D. of three independent experiments performed in techni-
cal triplicate. (B) HCT116 cells were treated for 72 h with 10 μM QVD-oPh and either 100 nM
Tg (left panel) or 2 μg ml-1 Tm (right panel) and colonies were analysed as in (A). Results
shown are the means ± S.D. for a single experiment performed in technical triplicate. (C)
NIH3T3 ΔCRAF:ER cells were pre-treated for 24 h with 100 nM 4-HT, prior to addition of
100 nM Tg (left panel) or 2 μg ml-1 Tm (right panel) for 24 h. Treatment media was removed
and colonies were left to grow for 7 days before crystal violet absorbance was measured follow-
ing staining. Results shown are from the combined means ± S.D. of five independent experi-
ments performed in technical triplicate, displayed as the % staining compared to DMSO
treated control and coefficient of variation. Student’s unpaired t-tests comparing colonies in
the presence and absence of ER stressor in (A) and (C) are indicated as; , p< 0.05; ,
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p< 0.01; , p< 0.001.
(TIF)
S10 Fig. Tm-induced cell death in wild type and Atg5-/- iMEFs. (A) Atg5 WT and Atg5-/-
iMEFs were treated for 48 h with the indicated concentration of Tm. Cells were fixed and ana-
lysed by flow cytometry following propidium iodide staining. Results shown are the combined
means ± S.D. of three independent experiments performed in technical triplicate. (B) Atg5
WT and Atg5-/- iMEFs were treated with the indicated concentration of Tm for 24 h. Whole
cell lysates were analysed by immunoblotting using the indicated antibodies after fractionation
by SDS-PAGE. Results shown are representative of three independent experiments.
(TIF)
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